Question 1

What is the Meaning of FGF23?

Accepted Answer

FGF23, or Fibroblast Growth Factor 23, is a hormone primarily produced by osteocytes in bone. It plays a central role in regulating phosphate and vitamin D metabolism, acting as a phosphaturic hormone. Its primary function involves promoting renal phosphate excretion and suppressing calcitriol production, thereby maintaining mineral balance within the body.

Question 2

What is the Context of FGF23?

Accepted Answer

FGF23 operates within the endocrine system, specifically as a key regulator of mineral homeostasis alongside parathyroid hormone (PTH) and calcitriol (1,25-dihydroxyvitamin D). Its actions are crucial for maintaining appropriate serum phosphate levels and preventing hyperphosphatemia, influencing bone mineralization and overall skeletal health. This hormone forms part of a complex feedback loop that adapts to dietary phosphate intake and kidney function.

Question 3

What is the Significance of FGF23?

Accepted Answer

Clinically, FGF23 levels are important indicators in various phosphate wasting disorders and chronic kidney disease. Elevated FGF23 can contribute to hypophosphatemia, osteomalacia, and rickets, while its retention in kidney disease is linked to secondary hyperparathyroidism, cardiovascular calcification, and increased mortality. Understanding its dynamics helps guide therapeutic strategies and predict disease progression in patients.

Question 4

What is the Mechanism of FGF23?

Accepted Answer

FGF23 exerts its effects by binding to fibroblast growth factor receptors (FGFRs), primarily FGFR1, in conjunction with its co-receptor α-Klotho, found predominantly in the renal tubules. This binding initiates intracellular signaling pathways that lead to the downregulation of sodium-phosphate co-transporters (NaPi-IIa and NaPi-IIc) in the kidney, reducing phosphate reabsorption. It also suppresses 1-alpha-hydroxylase activity in the kidney, decreasing calcitriol synthesis.

Question 5

What is the Application of FGF23?

Accepted Answer

In clinical practice, managing FGF23 is vital in conditions like X-linked hypophosphatemia (XLH), tumor-induced osteomalacia (TIO), and chronic kidney disease (CKD). Therapeutic approaches might involve phosphate supplementation, active vitamin D analogs, or, in specific cases, FGF23-blocking antibodies to correct phosphate imbalances and improve bone health. Monitoring FGF23 is integral to personalized treatment plans.

Question 6

What is the Metric of FGF23?

Accepted Answer

FGF23 levels are measured through specific blood tests, typically an enzyme-linked immunosorbent assay (ELISA) or immunoradiometric assay (IRMA) from a serum sample. These measurements help diagnose and monitor phosphate disorders, assess disease progression in CKD, and evaluate the effectiveness of interventions aimed at mineral balance. Reference ranges vary slightly depending on the laboratory and assay used.

Question 7

What is the Risk of FGF23?

Accepted Answer

Dysregulation of FGF23 can lead to significant health complications. Chronically elevated FGF23, as seen in advanced kidney disease, is associated with increased cardiovascular risk, left ventricular hypertrophy, and mortality. Conversely, very low FGF23 activity, although rare, can contribute to hyperphosphatemia and ectopic calcification, necessitating careful clinical management to avoid adverse outcomes and maintain patient well-being.

FGF23

Meaning

Context

Significance

Mechanism

Application

Metric

Risk

Can Growth Hormone Therapy Affect Electrolyte Balance beyond Sodium?

Provided by the clinical team
at 4Ever Young Miami Dadeland

-15% ∞ HRTIO15

Your protocol begins with a conversation.

Visit

Schedule Appointment

About

Med & Wellness

4Ever Young Miami Dadeland

Communication

+1 786-529-6686

Email Us

Opening Hours